Exhibit 99.1
| Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com |
June 23, 2025
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Ltd. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
Ref: | Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 |
Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs
This is to inform you that the Company has allotted 10,685 equity shares of Re.1/- each of the Company, fully paid up, on June 23, 2025, to eligible employees pursuant to exercise of their Stock Options under Dr. Reddy’s Employees Stock Options Scheme, 2002 and Dr. Reddy’s Employees ADR Stock Options Scheme, 2007.
Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
Encl: as above
| Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com
|
Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
1 | Company name and address of Registered Office: |
2 | Name of the Stock Exchanges on which the company’s shares are listed: NSE IFSC Limited (ADRs) |
3 | Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange:
The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. |
4 | Filing Number, if any: NA |
5 | Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy’s Employees Stock Options Scheme, 2002 Dr. Reddy’s Employees ADR Stock Options Scheme, 2007 |
6 | Kind of security to be listed: Equity Shares |
7 | Par value of the shares: Re. 1/- |
8 | Date of issue of shares: June 23, 2025 (Date of allotment on exercise) |
9 | Number of shares issued: 10,685 equity shares |
10 | Share Certificate No., if applicable: NA |
11 | Distinctive number of the share, if applicable: 834571091 to 834581775 |
12 | ISIN Number of the shares if issued in Demat: INE089A01031 |
13 | Exercise price per share: i. 4,265 equity shares exercised at Re.1/- per share ii. 5,800 equity shares exercised at Rs. 735.80/- per share iii. 620 equity shares exercised at Rs. 1,060.20/- per share |
14 | Premium per share: i. 4,265 equity shares exercised - Nil ii. 5,800 equity shares exercised at Rs. 734.80/- per share iii. 620 equity shares exercised at Rs. 1,059.20/- per share |
15 | Total Issued shares after this issue: 83,45,82,775 (*) |
16 | Total Issued share capital after this issue: Rs. 83,45,82,775/- |
17 | Details of any lock-in on the shares: NA |
18 | Date of expiry of lock-in: NA |
19 | Whether shares identical in all respects to existing shares if not, when will they become identical? |
20 | Details of listing fees, if payable: NA |
(*) Total paid up capital after this issue: 83,45,81,775 equity shares of Re.1 each, aggregating to Rs. 83,45,81,775/- (difference of 1,000 due to forfeited shares of Re. 1/- each in September 1988 on account of non-payment of allotment money.)